CRL vs MD · rev $2.00B vs P/E 11, rev $964.0M
Charles River Laboratories (CRL) versus Mednax Inc (MD) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Mednax Inc (MD) is a medical care facilities company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported MD revenue for 2026-06-30 was $964.0M. Net income was $69.4M. MD currently screens at market cap $1.93B and trailing P/E 11.4.
CRL currently screens at market cap $7.78B. MD currently screens at market cap $1.93B and trailing P/E 11.4.
Not investment advice. Open the CRL and MD stock pages for the full models.
Not investment advice.